AI Makes Retinal Imaging 100 Times Faster

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is 100 times faster and improves image contrast 3.5-fold. The advance, they say, will provide researchers with a better tool to evaluate age-related macular degeneration (AMD) and other retinal diseases.

"Artificial intelligence helps overcome a key limitation of imaging cells in the retina, which is time," said Johnny Tam, Ph.D., who leads the Clinical and Translational Imaging Section at NIH's National Eye Institute.

Tam is developing a technology called adaptive optics (AO) to improve imaging devices based on optical coherence tomography (OCT). Like ultrasound, OCT is noninvasive, quick, painless, and standard equipment in most eye clinics.

Imaging RPE cells with AO-OCT comes with new challenges, including a phenomenon called speckle. Speckle interferes with AO-OCT the way clouds interfere with aerial photography. At any given moment, parts of the image may be obscured. Managing speckle is somewhat similar to managing cloud cover. Researchers repeatedly image cells over a long period of time. As time passes, the speckle shifts, which allows different parts of the cells to become visible. The scientists then undertake the laborious and time-consuming task of piecing together many images to create an image of the RPE cells that's speckle-free.

Tam and his team developed a novel AI-based method called parallel discriminator generative adverbial network (P-GAN) - a deep learning algorithm. By feeding the P-GAN network nearly 6,000 manually analyzed AO-OCT-acquired images of human RPE, each paired with its corresponding speckled original, the team trained the network to identify and recover speckle-obscured cellular features.

When tested on new images, P-GAN successfully de-speckled the RPE images, recovering cellular details. With one image capture, it generated results comparable to the manual method, which required the acquisition and averaging of 120 images. With a variety of objective performance metrics that assess things like cell shape and structure, P-GAN outperformed other AI techniques. Vineeta Das, Ph.D., a postdoctoral fellow in the Clinical and Translational Imaging Section at NEI, estimates that P-GAN reduced imaging acquisition and processing time by about 100-fold. P-GAN also yielded greater contrast, about 3.5 greater than before.

"Adaptive optics takes OCT-based imaging to the next level," said Tam. "It's like moving from a balcony seat to a front row seat to image the retina. With AO, we can reveal 3D retinal structures at cellular-scale resolution, enabling us to zoom in on very early signs of disease."

While adding AO to OCT provides a much better view of cells, processing AO-OCT images after they’ve been captured takes much longer than OCT without AO.

Tam's latest work targets the retinal pigment epithelium (RPE), a layer of tissue behind the light-sensing retina that supports the metabolically active retinal neurons, including the photoreceptors. The retina lines the back of the eye and captures, processes, and converts the light that enters the front of the eye into signals that it then transmits through the optic nerve to the brain. Scientists are interested in the RPE because many diseases of the retina occur when the RPE breaks down.

By integrating AI with AO-OCT, Tam believes that a major obstacle for routine clinical imaging using AO-OCT has been overcome, especially for diseases that affect the RPE, which has traditionally been difficult to image.

"Our results suggest that AI can fundamentally change how images are captured," said Tam. "Our P-GAN artificial intelligence will make AO imaging more accessible for routine clinical applications and for studies aimed at understanding the structure, function, and pathophysiology of blinding retinal diseases. Thinking about AI as a part of the overall imaging system, as opposed to a tool that is only applied after images have been captured, is a paradigm shift for the field of AI."

Vineeta Das, Furu Zhang, Andrew Bower, et al.
Revealing speckle obscured living human retinal cells with artificial intelligence assisted adaptive optics optical coherence tomography.
Communications Medicine, 2024. doi: 10.1038/s43856-024-00483-1

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...